Global Celiac Drugs Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI52418
  • May 03, 2019
  • Global
  • 106 pages
  • QY Market Research
                                          

"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Celiac Drugs market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Celiac Drugs market." Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the bodys inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the bodys ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjogrens syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.  North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region.  The global Celiac Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Celiac Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Celiac Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: ADMA Biologics Amgen Anthera Pharmaceuticals Bayer Biogen BioLineRx Biotest Bristol-Myers Squibb Celgene Celimmune F Hoffmann-La Roche ImmunogenX Immunomedics ImmusanT Innovate Biopharmaceuticals Johnson & Johnson Kedrion Biopharma LFB Group Merck Novartis Segment by Regions North America Europe China Japan Segment by Type First Line Of Treatment Second Line Of Treatment Segment by Application Men Women Children

Table of Contents

Executive Summary
1 Celiac Drugs Market Overview
    1.1 Product Overview and Scope of Celiac Drugs
    1.2 Celiac Drugs Segment by Type
        1.2.1 Global Celiac Drugs Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 First Line Of Treatment
        1.2.3 Second Line Of Treatment
    1.3 Celiac Drugs Segment by Application
        1.3.1 Celiac Drugs Consumption Comparison by Application (2014-2025)
        1.3.2 Men
        1.3.3 Women
        1.3.4 Children
    1.4 Global Celiac Drugs Market by Region
        1.4.1 Global Celiac Drugs Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Celiac Drugs Market Size
        1.5.1 Global Celiac Drugs Revenue (2014-2025)
        1.5.2 Global Celiac Drugs Production (2014-2025)

2 Global Celiac Drugs Market Competition by Manufacturers
    2.1 Global Celiac Drugs Production Market Share by Manufacturers (2014-2019)
    2.2 Global Celiac Drugs Revenue Share by Manufacturers (2014-2019)
    2.3 Global Celiac Drugs Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Celiac Drugs Production Sites, Area Served, Product Types
    2.5 Celiac Drugs Market Competitive Situation and Trends
        2.5.1 Celiac Drugs Market Concentration Rate
        2.5.2 Celiac Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Celiac Drugs Production Market Share by Regions
    3.1 Global Celiac Drugs Production Market Share by Regions
    3.2 Global Celiac Drugs Revenue Market Share by Regions (2014-2019)
    3.3 Global Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
    3.4 North America Celiac Drugs Production
        3.4.1 North America Celiac Drugs Production Growth Rate (2014-2019)
        3.4.2 North America Celiac Drugs Production, Revenue, Price and Gross Margin (2014-2019)
    3.5 Europe Celiac Drugs Production
       ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form